JP2023550543A5 - - Google Patents

Info

Publication number
JP2023550543A5
JP2023550543A5 JP2023551946A JP2023551946A JP2023550543A5 JP 2023550543 A5 JP2023550543 A5 JP 2023550543A5 JP 2023551946 A JP2023551946 A JP 2023551946A JP 2023551946 A JP2023551946 A JP 2023551946A JP 2023550543 A5 JP2023550543 A5 JP 2023550543A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
compound according
alkyl
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023551946A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023550543A (ja
JP7884275B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/057563 external-priority patent/WO2022094400A1/en
Publication of JP2023550543A publication Critical patent/JP2023550543A/ja
Publication of JP2023550543A5 publication Critical patent/JP2023550543A5/ja
Application granted granted Critical
Publication of JP7884275B2 publication Critical patent/JP7884275B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023551946A 2020-11-02 2021-11-01 二環式化合物及び疾患の治療のためのその使用 Active JP7884275B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063108660P 2020-11-02 2020-11-02
US63/108,660 2020-11-02
PCT/US2021/057563 WO2022094400A1 (en) 2020-11-02 2021-11-01 Bicyclic compounds and uses thereof for the treatment of diseases

Publications (3)

Publication Number Publication Date
JP2023550543A JP2023550543A (ja) 2023-12-01
JP2023550543A5 true JP2023550543A5 (cg-RX-API-DMAC7.html) 2024-11-06
JP7884275B2 JP7884275B2 (ja) 2026-07-03

Family

ID=81384389

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023551946A Active JP7884275B2 (ja) 2020-11-02 2021-11-01 二環式化合物及び疾患の治療のためのその使用

Country Status (13)

Country Link
US (1) US20240025903A1 (cg-RX-API-DMAC7.html)
EP (1) EP4236944A4 (cg-RX-API-DMAC7.html)
JP (1) JP7884275B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230104191A (cg-RX-API-DMAC7.html)
CN (2) CN116568301A (cg-RX-API-DMAC7.html)
AR (1) AR124637A1 (cg-RX-API-DMAC7.html)
AU (1) AU2021371026A1 (cg-RX-API-DMAC7.html)
CA (1) CA3196582A1 (cg-RX-API-DMAC7.html)
CL (2) CL2023001195A1 (cg-RX-API-DMAC7.html)
IL (1) IL302465A (cg-RX-API-DMAC7.html)
MX (1) MX2023004942A (cg-RX-API-DMAC7.html)
TW (1) TWI918751B (cg-RX-API-DMAC7.html)
WO (1) WO2022094400A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL313039A (en) * 2021-12-17 2024-07-01 Athira Pharma Inc Uses of bicyclic compounds for the treatment of diseases
KR20250005323A (ko) * 2022-05-04 2025-01-09 아티라 파마, 인코포레이티드 신경병증을 치료하는 방법
US20250275976A1 (en) * 2022-05-04 2025-09-04 Athira Pharma, Inc. Methods of Treating Neuroinflammatory Conditions
JP2025538382A (ja) 2022-11-18 2025-11-28 アティラ・ファーマ・インコーポレイテッド 炎症病態を治療する方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184223B1 (en) * 1995-10-27 2001-02-06 Molecumetics Ltd. Reverse-turn mimetics and methods relating thereto
WO2004035587A1 (en) 2002-10-17 2004-04-29 Myriad Genetics, Inc. Reverse-turn mimetics and composition and methods relating thereto
US7192976B2 (en) * 2002-12-21 2007-03-20 Angion Biomedica Corporation Small molecule modulators of hepatocyte growth factor (scatter factor) activity
WO2006036981A2 (en) * 2004-09-28 2006-04-06 Angion Biomedica Corp. Small molecule modulators of cytokine activity
US7879898B1 (en) * 2006-02-14 2011-02-01 Angion Biomedica Corp. Hepatocyte growth factor pathway activators in chronic obstructive pulmonary disease
EP1947085A1 (en) * 2007-01-19 2008-07-23 Laboratorios del Dr. Esteve S.A. Substituted indole sulfonamide compounds, their preparation and use as medicaments
US8691819B2 (en) * 2008-10-14 2014-04-08 Prism Biolab Corporation Alpha helix mimetic compositions for treating cancer and other CBP/catenin-mediated diseases and conditions
US20160074400A1 (en) * 2012-08-06 2016-03-17 University Of Southern California Wnt modulators for the protection, mitigation and treatment of radiation injury
EP3366687B1 (en) * 2015-09-18 2020-04-29 National University Corporation Tottori University Suppression and regeneration promoting effect of low molecular weight compound on cancer and fibrosis

Similar Documents

Publication Publication Date Title
CA2505195A1 (en) Quinazolinones as potassium channel modulators
RU2019131111A (ru) ПРОИЗВОДНОЕ ГЕТЕРОАРИЛ[4,3-с]ПИРИМИДИН-5-АМИНА, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ЕГО МЕДИЦИНСКИЕ ПРИМЕНЕНИЯ
RU2020108515A (ru) Соединения и способы целевого расщепления андрогенного рецептора
RU2009132189A (ru) Новые 2-аминооксазолины в качестве лигандов taar1
CA2441565A1 (en) Bisarylamines as potassium channel openers
JP2014051526A5 (cg-RX-API-DMAC7.html)
JP2012515166A5 (cg-RX-API-DMAC7.html)
JP2016534134A5 (cg-RX-API-DMAC7.html)
JP2018502912A5 (cg-RX-API-DMAC7.html)
DE602004017316D1 (de) Heteroaryl-tetrahydropyridylverbindungen, die sich für die behandlung bzw. die prävention von schmerzen eignen
JP2018505898A5 (cg-RX-API-DMAC7.html)
TN2015000382A1 (en) Perfluorinated cyclopropyl fused 1,3- oxazin -2- amine compounds as beta- secretase inhibitors and methods of use
HUP0103530A2 (hu) N,N-szubsztituált ciklusos aminvegyületek és ezeket tartalmazó gyógyászati készítmények
RU2002128352A (ru) Производные 4,5-дигидро-1н-пиразола, обладающие cb1-антагонистической активностью
JP2013525458A5 (cg-RX-API-DMAC7.html)
JP2024517498A5 (cg-RX-API-DMAC7.html)
JP2017533968A5 (cg-RX-API-DMAC7.html)
JP2011527686A5 (cg-RX-API-DMAC7.html)
JP2013538801A5 (cg-RX-API-DMAC7.html)
JPWO2002010101A1 (ja) アミド化合物を配位子とする遷移金属錯体を用いたアルコールの製造方法
NZ590951A (en) Cyclic nucleotide phosphodiesterases PDE10 inhibitors for treating neurological disorders
RU2009103307A (ru) ПРОИЗВОДНЫЕ ИМИДАЗО[1, 2-a]ПИРИДИН-2-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В ТЕРАПИИ
JP2013533253A5 (cg-RX-API-DMAC7.html)
MX2016008842A (es) Derivados de n-fenil-lactama capaces de estimular la neurogenesis y su uso en el tratamiento de trastornos neurologicos.
RU2007116987A (ru) Новые соединения